Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. [electronic resource]
- Bioorganic & medicinal chemistry letters 10 2016
- 4837-4841 p. digital
Publication Type: Journal Article
1464-3405
10.1016/j.bmcl.2016.08.010 doi
Crystallography, X-Ray Drug Discovery Fluorescence Resonance Energy Transfer Molecular Conformation Proto-Oncogene Proteins c-mdm2--antagonists & inhibitors Tumor Suppressor Protein p53--antagonists & inhibitors